STOCK TITAN

Celestica SEC Filings

CLS NYSE

Welcome to our dedicated page for Celestica SEC filings (Ticker: CLS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

Celestica Inc. (CLS) files a range of documents with the U.S. Securities and Exchange Commission that provide detailed insight into its operations, governance and financial performance. As an Ontario, Canada corporation with common shares listed on the New York Stock Exchange, Celestica submits reports under the Exchange Act, including current reports on Form 8-K that disclose material events.

Recent Form 8-K filings illustrate the types of information investors can expect. Celestica has reported quarterly financial results and related conference calls, furnished press releases as exhibits, and described its guidance and outlook for revenue, adjusted operating margin, adjusted EPS and non-GAAP free cash flow. Other 8-Ks detail corporate actions such as the launch and acceptance of a normal course issuer bid on the Toronto Stock Exchange to repurchase a portion of its public float, with information on the maximum number of shares, timing and cancellation of repurchased shares.

The company’s filings also cover governance and Board matters. Examples include the appointment of new independent directors, committee assignments, and planned transitions such as the resignation of a director and the designation of a new Audit Committee Chair. These disclosures provide transparency into Celestica’s oversight structure and the experience of its Board members.

Through this SEC filings page on Stock Titan, users can access Celestica’s regulatory documents as they are made available on EDGAR. AI-powered summaries help explain key points from lengthy filings, including financial results, segment commentary for Advanced Technology Solutions (ATS) and Connectivity & Cloud Solutions (CCS), capital allocation decisions like issuer bids, and changes in corporate governance. Investors can also review insider and executive-related disclosures contained in applicable forms to better understand leadership and oversight at Celestica.

Rhea-AI Summary

Celestica Inc. reported an insider equity transaction by its President. On 12/01/2025, the officer acquired 17,792 common shares through the vesting and settlement of restricted share units at an exercise price of $0, increasing directly held shares. On the same date, 8,248 common shares were disposed of at $344.41 per share to cover tax withholding obligations tied to the RSU vesting. Following these transactions, the officer directly owned 108,970 common shares. The underlying RSU award covered 17,792 common shares and was fully settled, leaving no derivative securities from that grant outstanding.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Celestica Inc. Chief Operations Officer reports RSU vesting, tax withholding, and share sale. On 12/01/2025, 17,792 common shares were acquired at an exercise price of $0 upon the vesting and settlement of restricted share units (RSUs). On the same date, 8,605 of these shares were disposed of at $323.38 per share to cover tax withholding obligations, and 9,187 shares were sold in a market transaction at $323.38 per share, leaving 0 common shares held directly after these transactions.

These activities relate to an RSU grant of 53,375 units awarded on January 31, 2023, which vests ratably over three years, including on December 1 following the second anniversary of the grant date. Each RSU represents a contingent right to receive one common share or an equivalent cash amount at the holder’s election.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Filing
Rhea-AI Summary

Celestica Inc. insider plans to sell common shares under Rule 144. A notice reports a proposed sale of 3,160 common shares through broker Canaccord Genuity on the NYSE, with an aggregate market value of 1,088,335.60. The filing notes that 115,036,621 shares of the issuer were outstanding. The shares to be sold were acquired on 12/01/2025 through the vesting of restricted share units from Celestica Inc., with the same date listed for acquisition and payment.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
Rhea-AI Summary

Celestica Inc. insider filed a Form 144 notice to sell up to 9,186 common shares through broker Canaccord Genuity on the NYSE, with an approximate sale date of 12/01/2025. The filing lists an aggregate market value of these shares of $3,163,750.26. The 9,186 shares were acquired on 12/01/2025 through restricted share unit vesting from Celestica Inc. Shares outstanding were 115,036,621 at the time referenced, providing context for the size of this planned sale.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
-
Rhea-AI Summary

Celestica (CLS) reported a director’s open‑market purchases on 10/30/2025. The filing lists four buy transactions totaling 6,000 common shares, at weighted average prices of $339.68 (700 shares), $340.55 (600), $341.96 (3,227), and $342.44 (1,473). Following these trades, the director beneficially owns 6,000 shares, held directly. No derivative securities were reported.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.7%
Tags
insider
-
Rhea-AI Summary

Celestica Inc. (CLS) announced final acceptance from the Toronto Stock Exchange for a normal course issuer bid to repurchase up to 5,722,527 common shares, representing approximately 5 percent of the outstanding public float as of October 20, 2025. The NCIB will run from November 3, 2025 to November 2, 2026. The company furnished the related press release as Exhibit 99.1.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.7%
Tags
current report
Rhea-AI Summary

Celestica Inc. (CLS) — Form 3 initial ownership filing

A newly reported director filed a Form 3 reflecting their status under Section 16. As of the event date 10/27/2025, the filing states no securities are beneficially owned. The form was submitted by an attorney‑in‑fact pursuant to a Power of Attorney (Exhibit 24.1) and indicates it was filed by one reporting person.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Celestica Inc. (CLS) appointed Laurette T. Koellner to its Board of Directors, effective October 27, 2025. The Board determined she is an independent director under Canadian securities laws and NYSE listing standards.

Koellner will serve on the Audit, Human Resources and Compensation, and Nominating and Corporate Governance committees. She previously served on Celestica’s Board before stepping down in January 2025 and returns with senior leadership experience at International Lease Finance Corporation and The Boeing Company. She will be compensated according to existing Board director policies.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
8.16%
Tags
current report
-
Rhea-AI Summary

Celestica Inc. (CLS) furnished an Investor and Analyst Day presentation under Item 7.01. On October 28, 2025, the company posted the deck on its investor website for use during its conference call covering results for the quarter ended September 30, 2025 and Investor and Analyst Day. The presentation is included as Exhibit 99.1.

The information provided under Item 7.01, including Exhibit 99.1, is furnished and not filed under the Exchange Act.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
8.16%
Tags
current report
Rhea-AI Summary

Celestica Inc. reported strong Q3 2025 results. Revenue rose to $3,194.0 million from $2,499.5 million a year ago, and net earnings increased to $267.8 million. Diluted EPS was $2.31 versus $0.75. Earnings from operations reached $325.0 million, driven by higher gross profit of $416.1 million and lower SG&A. Q3 operating cash flow was $126.2 million.

CCS led growth with $2,413.0 million (76% of total), including Communications $1,942.9 million and Enterprise $470.1 million. ATS delivered $781.0 million. Reconciling items included a total return swap fair value gain of $113.3 million and amortization of intangible assets of $10.0 million. Total assets were $6,606.7 million; total liabilities were $4,578.1 million. Term loans outstanding were $728.1 million with cash and cash equivalents of $305.9 million. Shares outstanding were 115,036,621 as of October 22, 2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
8.16%
Tags
quarterly report

FAQ

How many Celestica (CLS) SEC filings are available on StockTitan?

StockTitan tracks 99 SEC filings for Celestica (CLS), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for Celestica (CLS)?

The most recent SEC filing for Celestica (CLS) was filed on December 2, 2025.